⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 1, 2024

F-Florbetaben PET/CT for the Diagnosis and Subtyping of Cardiac Amyloidosis: A Case Series and Review of the Literature.

Y.-C. Shih Bing‐Hsiean Tzeng Meng-Chieh Tsai Yuan‐Bin Yu Yu‐Chien Shiau Shan-Ying Wang Yen‐Wen Wu

View Full Paper

Ask AI

Bookmark

Share

Abstract

Cardiac amyloidosis (CA) is a type of systemic amyloidosis. Amyloid-targeting positron emission tomography (PET) has shown potential as an imaging method for CA. However, the optimal imaging protocol and role of

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Shih et al. (2024) studied this question.

synapsesocial.com/papers/68e59d93b6db6435875382be https://doi.org/10.6515/acs.202409_40(5).20240617d

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

118F-Florbetaben PET Detection of Cardiac and Multi-Organ Involvement for Identifying AL and ATTR Cardiac Amyloidosiscross-sectional · 2026 · 2 citations
218F-flutemetamol positron emission tomography in cardiac amyloidosiscross-sectional · 2020 · 45 citations
3Nuclear Medicine Techniques in the Diagnosis of Cardiac Amyloidosis2025
4Prognostic parameters and detection of cardiac amyloidosis with hybrid 18F-Florbetaben-PET/MRI: an exploratory observational studyObservational Study · 2026 · 1 citations
5Florbetaben PET for early and non-invasive diagnosis of light chain amyloidosis: a case report and brief review of the literatureCase Report · 2026